- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Roxana Siles: QOL Improves Greatly From Effective Chronic Cough Treatment
Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, address the impact of effective treatments of chronic cough on patient quality of life (QOL).
Patients can get embarrassed or rethink venturing out, whether that be to church, the theater, or to dinner, so effective treatments for chronic cough can have a positive impact on their work and home lives, noted Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic.
Transcript
What impact might an effective treatment that resolves the symptoms of chronic cough have on quality of life?
When patients come to our office with a chief complaint of chronic cough, these are the patients who think twice before going to church or going to a theater or going out for dinner. And I think, unfortunately, this has been even more so now in the age of COVID. A lot of times, they are embarrassed, or they just don’t want to be getting dirty looks by coughing—again, especially now. So it can really make a difference.
I do also see a lot of patients whose work requires a lot of talking to customers or employees and it’s really hard for them to be able to maintain a conversation or do a presentation without coughing. So, it could certainly impact not only the quality of life in general, but also their work. And, as I said, sometimes they’re coughing at night and not sleeping well, so it can play a role in many aspects of their daily lives. And I think it’s a huge thing for them.
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
